Cargando…
Association between Pre-Existing Long-Term β-Blocker Therapy and the Outcomes of Sepsis-Associated Coagulopathy: A Retrospective Study
Background and Objectives: Previous studies have suggested that long-term β-blocker therapy before sepsis is associated with reduced mortality. Sepsis-associated coagulopathy (SAC) remains a common complication in patients with sepsis and is associated with increased mortality. Adrenergic pathways a...
Autores principales: | Ma, Ying, Ma, Jie, Yang, Jiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786011/ https://www.ncbi.nlm.nih.gov/pubmed/36557045 http://dx.doi.org/10.3390/medicina58121843 |
Ejemplares similares
-
Association between hypomagnesemia and coagulopathy in sepsis: a retrospective observational study
por: Tonai, Ken, et al.
Publicado: (2022) -
Comparison of the coagulopathies associated with COVID‐19 and sepsis
por: Campbell, Robert A., et al.
Publicado: (2021) -
The Long Term Residual Effects of COVID-Associated Coagulopathy
por: Ranucci, Marco, et al.
Publicado: (2023) -
β1-blocker in sepsis
por: Hasegawa, Daisuke, et al.
Publicado: (2021) -
Long-term clinical outcomes in critically ill patients with sepsis and pre-existing low muscle mass: a retrospective cohort study
por: Darden, Nola, et al.
Publicado: (2023)